2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Keratosis, Actinic
7
Neoplasms
5
Melanoma
3
Warts
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Hyperthermia
2
Hematologic Neoplasms
2
Hemangioma
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Tuberous Sclerosis
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors Harboring NTRK Fusion
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Seizures
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Polycystic Ovary Syndrome
1
Pituitary Neoplasms
1
Pelvic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Obesity
1
Nonmelanoma Skin Cancers
1
Mucositis
1
Interventions
Everolimus
18
Sirolimus
15
Cannabidiol
6
radiprodil
3
ganaxolone
3
Vigabatrin
3
Activator Appliances
3
Melatonin
2
exemestane
1
dactolisib
1
carbon-11 acetate
1
Urination
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Solutions
1
Simvastatin
1
Sertraline
1
Selective Serotonin Reuptake Inhibitors
1
Propranolol
1
Phlebotomy
1
Itraconazole
1
Injections
1
Genetic Testing
1
Fluid Therapy
1
Doxycycline
1
Curcumin
1
Carbamazepine
1
Calcitriol
1
Aspirin
1
Anticonvulsants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Tuberous Sclerosis
×
Solutions
×
Clear all
NCT05485831
2026-02-17
EpiTALY
Jazz Pharmaceuticals
Recruiting
100 enrolled